These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
767 related articles for article (PubMed ID: 21803851)
1. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851 [TBL] [Abstract][Full Text] [Related]
2. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells. Pan F; Wingo TS; Zhao Z; Gao R; Makishima H; Qu G; Lin L; Yu M; Ortega JR; Wang J; Nazha A; Chen L; Yao B; Liu C; Chen S; Weeks O; Ni H; Phillips BL; Huang S; Wang J; He C; Li GM; Radivoyevitch T; Aifantis I; Maciejewski JP; Yang FC; Jin P; Xu M Nat Commun; 2017 Apr; 8():15102. PubMed ID: 28440315 [TBL] [Abstract][Full Text] [Related]
3. [Functional analysis of TET2 using a knockdown mouse model]. Shide K; Kameda T; Shimoda K Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876 [TBL] [Abstract][Full Text] [Related]
4. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2 Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626 [TBL] [Abstract][Full Text] [Related]
5. Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells. Kunimoto H; Fukuchi Y; Sakurai M; Sadahira K; Ikeda Y; Okamoto S; Nakajima H Sci Rep; 2012; 2():273. PubMed ID: 22355785 [TBL] [Abstract][Full Text] [Related]
6. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis. Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061 [TBL] [Abstract][Full Text] [Related]
7. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190 [TBL] [Abstract][Full Text] [Related]
8. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711 [TBL] [Abstract][Full Text] [Related]
9. TET proteins and 5-methylcytosine oxidation in hematological cancers. Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268 [TBL] [Abstract][Full Text] [Related]
10. [TET2 as a gatekeeper for hematologic malignancies]. Muto H; Sakata-Yanagimoto M; Chiba S Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875 [TBL] [Abstract][Full Text] [Related]
11. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Ko M; Huang Y; Jankowska AM; Pape UJ; Tahiliani M; Bandukwala HS; An J; Lamperti ED; Koh KP; Ganetzky R; Liu XS; Aravind L; Agarwal S; Maciejewski JP; Rao A Nature; 2010 Dec; 468(7325):839-43. PubMed ID: 21057493 [TBL] [Abstract][Full Text] [Related]
12. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Pronier E; Almire C; Mokrani H; Vasanthakumar A; Simon A; da Costa Reis Monte Mor B; Massé A; Le Couédic JP; Pendino F; Carbonne B; Larghero J; Ravanat JL; Casadevall N; Bernard OA; Droin N; Solary E; Godley LA; Vainchenker W; Plo I; Delhommeau F Blood; 2011 Sep; 118(9):2551-5. PubMed ID: 21734233 [TBL] [Abstract][Full Text] [Related]
15. The TET2 interactors and their links to hematological malignancies. Pan F; Weeks O; Yang FC; Xu M IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018 [TBL] [Abstract][Full Text] [Related]
16. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cheng J; Guo S; Chen S; Mastriano SJ; Liu C; D'Alessio AC; Hysolli E; Guo Y; Yao H; Megyola CM; Li D; Liu J; Pan W; Roden CA; Zhou XL; Heydari K; Chen J; Park IH; Ding Y; Zhang Y; Lu J Cell Rep; 2013 Oct; 5(2):471-81. PubMed ID: 24120864 [TBL] [Abstract][Full Text] [Related]
17. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis. Nakajima H; Kunimoto H Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794 [TBL] [Abstract][Full Text] [Related]
18. [TET2 gene in hematological diseases]. Li S; Wang XQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):836-41. PubMed ID: 24989305 [TBL] [Abstract][Full Text] [Related]
19. Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. Muto T; Sashida G; Oshima M; Wendt GR; Mochizuki-Kashio M; Nagata Y; Sanada M; Miyagi S; Saraya A; Kamio A; Nagae G; Nakaseko C; Yokote K; Shimoda K; Koseki H; Suzuki Y; Sugano S; Aburatani H; Ogawa S; Iwama A J Exp Med; 2013 Nov; 210(12):2627-39. PubMed ID: 24218139 [TBL] [Abstract][Full Text] [Related]